Is Hyperparathyroidism hereditary?

While most cases of hyperparathyroidism are sporadic and non-hereditary, approximately 5% to 10% of cases are linked to underlying genetic syndromes that are inherited. Whether hyperparathyroidism is hereditary depends entirely on the specific genetic mutation present, which distinguishes between isolated cases caused by environmental or unknown factors and those passed down through families.

Is hyperparathyroidism hereditary or sporadic?

In the vast majority of patients, hyperparathyroidism is a sporadic condition, meaning it occurs due to a benign tumor (adenoma) or hyperplasia of the parathyroid glands without a family history. However, when hyperparathyroidism is part of a familial endocrine syndrome, it follows a hereditary pattern. Distinguishing between these is vital; sporadic cases do not require genetic screening for family members, whereas hereditary forms imply that siblings, parents, and children may also be at risk of developing hyperparathyroidism or related endocrine tumors.

What are the genetic patterns associated with hereditary hyperparathyroidism?

When hyperparathyroidism is hereditary, it is most commonly inherited in an autosomal dominant pattern. This means an affected individual has a 50% chance of passing the genetic mutation to each of their children. The most common hereditary forms include:

• Multiple Endocrine Neoplasia type 1 (MEN1): Caused by mutations in the MEN1 gene.


• Multiple Endocrine Neoplasia type 2A (MEN2A): Caused by mutations in the RET proto-oncogene.


• Hyperparathyroidism-Jaw Tumor (HPT-JT) syndrome: Caused by mutations in the CDC73 gene.


• Familial Hypocalciuric Hypercalcemia (FHH): A benign condition that mimics hyperparathyroidism but is caused by mutations in the CASR gene.

When is genetic testing recommended for patients?

Genetic testing is not standard for every patient with elevated calcium levels, but it is strongly recommended if a patient meets specific clinical criteria. A clinical geneticist or endocrinologist will typically suggest testing if a patient exhibits any of the following:

1. Diagnosis of hyperparathyroidism at a young age (typically under 40).


2. A family history of parathyroid, pituitary, or pancreatic tumors.


3. Presence of multiple parathyroid tumors or parathyroid carcinoma.


4. Clinical findings suggestive of syndromic disease, such as kidney stones combined with specific endocrine symptoms.

What is the role of genetic counseling in this condition?

Genetic counseling is an essential step for families dealing with hereditary hyperparathyroidism. A counselor helps navigate the implications of a positive test result, assists in coordinating cascade testing for at-risk relatives, and provides guidance for those planning pregnancies. While de novo (spontaneous) mutations do occur—meaning the condition appears in a family with no prior history—these are less common than inherited forms in established syndromes. For families concerned about passing the gene to offspring, options such as preimplantation genetic testing (PGT) may be discussed during the counseling process.

Next steps

• Consult an endocrinologist to determine if your clinical presentation warrants genetic screening.


• Request a referral to a certified genetic counselor if you have a strong family history of endocrine tumors.


• Join the DiseaseMaps.org community to connect with 154 other members who have shared their experiences with this diagnosis.


• Maintain a detailed family health tree to share with your medical team during your consultation.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hyperparathyroidism overview.


• Orphanet: Rare endocrine diseases and genetic testing guidelines.


• OMIM (Online Mendelian Inheritance in Man): Clinical synopsis of MEN1 and HPT-JT syndromes.


• The Hormone Health Network: Understanding parathyroid disorders and genetic links.